US futures drop as bond yields, AI valuation fears rattle markets
US stock futures fall as tech and semiconductor shares slide, NVIDIA and AI infrastructure stocks weaken, bond yields and inflation fears rise, oil eases on reduced Iran strike risk
Uncategorized
BPCL Q4 Results: One-off impairment drags profit, but margins beat estimates
BPCL reported a mixed March quarter as strong refining margins and operating performance lifted EBITDA above estimates, while profit came under pressure due to a one-time impairment charge linked to its subsidiary.
Sensex, Nifty end lower after late sell-off in banks; IT rally continues
Closing Bell: Indian markets failed to hold early gains on Tuesday as weakness in financial stocks dragged benchmark indices lower, although broader markets remained resilient with continued buying in midcaps and information technology shares.
India clocks 77.6 crore digital payments daily as UPI deepens grip: RBI report
India processed 77.6 crore digital payment transactions every day in 2025, with annual volumes crossing ₹26,800 crore, according to RBI data. UPI continued to dominate everyday spending, accounting for over 85% of transactions by volume, while debit card usage dropped…
New India Assurance gets ₹256 crore tax refund; shares end higher
Shares of New India Assurance rose after the state-run insurer received a ₹255.68 crore income tax refund from the Income Tax Department for FY20.
PNC Infratech Q4 profit jumps 43% despite drop in revenue and margins
As per exchange fillings, revenue from operations declined 5.1% to ₹1,617 crore in the quarter against ₹1,704 crore in the corresponding period last year.
Hindalco arm Novelis reports Q4 loss as Oswego fires hit shipments, profitability
Hindalco Industries’ subsidiary Novelis reported a fourth-quarter loss after fires at its Oswego plant in the US disrupted production, hurt shipments and weighed on profitability despite resilient underlying demand.
Strides Pharma maintains up to $400 million FY28 target for North America, sees US recovery from H2FY27
Strides Pharma expects recovery in its US business from the second half of FY27 despite a weaker-than-expected flu season impacting recent growth, while reiterating its $375-400 million North America revenue target for FY28. It added that Ex-US markets are emerging…
Eureka Forbes Q4 revenue rises 12% on strong water purifier, robotics growth
Eureka Forbes reported healthy fourth-quarter growth led by water purifiers and emerging categories, while adjusted EBITDA margin touched a record high as the company continued its profitability and transformation push.
Explained – Why TVS Motor shares are down 13% in the last eight sessions
Brokerages Elara and Axis Capital have raised concerns regarding the TVS Motor’s capital allocation policy after the company announced a ₹193 crore investment in Jana Small Finance Bank.